Nicotine Replacement and Counseling In Adolescents
NCT00625794 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2008-02-28
Summary
The objective of this pilot study is to determine the feasibility and utility of using the nicotine nasal spray (NNS) in adolescent smokers who want to quit smoking.
Conditions
- Smoking Cessation
Interventions
- DRUG
-
Nicotine nasal spray
8 weeks or counseling plus 6 weeks of nicotine nasal spray (2 sprays each nostril as needed).
- BEHAVIORAL
-
Smoking cessation counseling
8 weeks or counseling
Sponsors & Collaborators
-
University of California, San Francisco
lead OTHER
Principal Investigators
-
Mark Rubinstein, MD · University of California, San Francisco
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 15 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2005-09-30
- Primary Completion
- 2007-05-31
- Completion
- 2007-07-31
Countries
- United States
Study Locations
More Related Trials
-
Study to Determine if a New Nicotine Replacement Therapy Can Safely Help Smokers to Quit Smoking
NCT01296698 ·Status: TERMINATED ·Phase: PHASE3
-
Nicotine Pharmacokinetics From Research Electronic Nicotine Delivery System S-TA-U001 in Smokers and E-Cigarette Users
NCT02792426 ·Status: COMPLETED ·Phase: PHASE1
-
Varenicline For Nicotine Vaping Cessation In Non Smoker Vaper Adolescents
NCT04602494 ·Status: TERMINATED ·Phase: PHASE4
-
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
NCT00365508 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of Using Reduced Nicotine Cigarettes in Men and Women Smokers to Combat Nicotine Addiction
NCT00264342 ·Status: COMPLETED
-
Effectiveness of Various Smoking Cessation Therapies in Reducing Smoking in Adolescents - 1
NCT00158171 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized Controlled Trial of Mailed Nicotine Replacement Therapy to Canadian Smokers
NCT01429129 ·Status: COMPLETED ·Phase: PHASE4
-
Medicinal Nicotine for Preventing Cue Induced Craving
NCT02347605 ·Status: COMPLETED ·Phase: NA
-
Smoking Reduction or Cessation With Nicotine Replacement Therapy
NCT00840242 ·Status: COMPLETED ·Phase: PHASE3
-
Varenicline for Adolescent Smoking Cessation
NCT01509547 ·Status: COMPLETED ·Phase: PHASE3
-
Galantamine Effects on Nicotine Responses in Smokers
NCT01417429 ·Status: COMPLETED ·Phase: PHASE1
-
Smoking Cessation Study In Healthy Adolescent Smokers
NCT01312909 ·Status: COMPLETED ·Phase: PHASE4
-
Electronic Cigarettes or Nicotine Inhaler for Smoking Cessation
NCT02004171 ·Status: WITHDRAWN ·Phase: NA
-
A Pilot Study Evaluating Nicotine Lozenges and Self Help
NCT00888459 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Bupropion for Treating Nicotine Dependence in Young People
NCT00129272 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Oral Tobacco Products Compared to a Medicinal Nicotine
NCT00710034 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Nicotine Nasal Spray as an Aid for Smoking Cessation in Schizophrenia
NCT01010477 ·Status: COMPLETED ·Phase: PHASE4
-
Varenicline for Nicotine Vaping Cessation in Adolescents
NCT05367492 ·Status: COMPLETED ·Phase: PHASE4
-
Stop Smoking Therapy for Ontario Patients
NCT00352781 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Bupropion for Treatment of Adolescent Smoking
NCT00248118 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Nicotine Reinforcement and Aversion in Young Adult Light Smokers
NCT01495819 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Smoking Cessation With Smokeless Tobacco, Nicotine Tablets and Nicotine Patches
NCT00313105 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Efficacy and Safety Study of Nicotine Mint Lozenge (2mg and 4mg) in Smoking Cessation
NCT00985985 ·Status: COMPLETED ·Phase: PHASE3
-
A Comprehensive Evaluation of Tobacco-Flavored vs. Non-Tobacco Flavored E-cigarettes on Smoking Behavior
NCT06260683 ·Status: RECRUITING ·Phase: NA
-
Tobacco Cessation in Postmenopausal Women (Part II) - 2
NCT00061074 ·Status: COMPLETED ·Phase: PHASE1